These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Bupranolol eye-drops (Ophtorenin) in long-term therapy of glaucoma (author's transl)].
    Author: Stiegler G.
    Journal: Klin Monbl Augenheilkd; 1979 Feb; 174(2):267-75. PubMed ID: 439706.
    Abstract:
    A clinical study with Bupranolol (Ophtorenin), a beta adrenergic blocking agent, is presented. 85 eyes with kinds species of glaucoma were treated during 22 months. A satisfying hypotensive effect was attained in a high percentage. Suitable combinations with Clonidine and Acetazolamide were tested. Based on its atoxic properties and lack of adverse reactions Bupranolol represents a valuable enlargement of glaucoma therapy.
    [Abstract] [Full Text] [Related] [New Search]